Advertisement
Screener

aTYR PHARMA INC (ATYR) Form D

aTYR PHARMA INC Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2017-09-15: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2017-08-31; Total offering amount $45,849,982.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2017-09-15Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2017-08-31$45,849,982$45,849,982$011

Similar stocks

Stock NameCountryMarket CapPE Ratio
Quince Therapeutics, Inc. (QNCX)United States$0.031B
CEL SCI CORP (CVM)United States$0.030B-0.81
Scilex Holding Co (SCLX)United States$0.042B-0.14
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
Estrella Immunopharma, Inc. (ESLA)United States$0.020B
LeonaBio, Inc. (LONA)United States$0.047B-0.61
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
Instil Bio, Inc. (TIL)United States$0.048B-1.73
Tevogen Inc. (TVGN)United States$0.049B
BioCardia, Inc. (BCDA)United States$0.016B